Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 37Terminated 16Recruiting 11Active not recruiting 11Unknown 8Withdrawn 3Suspended 2Not yet recruiting 1Enrolling by invitation 1Approved for marketing 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Pancreatic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Positron-Emission Tomography × Clear all
NCT05737615 2025-09-04

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

Memorial Sloan Kettering Cancer Center

Phase 1 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT03300401 2019-05-16

Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization

University of Southern California

Phase NA Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT02059889 2016-12-16

Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer

Virginia Commonwealth University

Phase NA Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡